The Romanian temporary Health minister Adriean Videanu claims that the company producing anti AH1N1 vaccinewill not take responsibility for the possible side effects the jab might have. Therefore, Romania changed its mind about buying 500,000 doses from producer company GlaxoSmithKline, which were planned to be used in children. "Following discussions, [the company] is not taking responsibility for this vaccine. If they don't find a solution, we'll chose the vaccine from Cantacuzino [Institute]. If we don't find common ground, we'll stick to the inner production", Adriean Videanu stated.
But the jab produced by the Cantacuzino Institute was not tested either, so possible side effects remain unknown. Videanu said tests must be operated on volunteers, but these are hard to find. In this context, the campaign for vaccinating children can no longer start on November 26.
PM Emil Boc requested during the last Government session for the 500,000 swine flu jab doses to not be imported except if GlaxoSmithKline took responsibility for the side-effects.
This follows the Government's decision from last week, when it was decided, in an emergency regime, to buy 500,000 doses of vaccine meant for children aged six months to 15 years. But the decision triggered controversies, since the jab was refused by Poland on the premises that it had not been sufficiently tested.
According to the Government's last week's decision, starting administrating the vaccine to children should have taken place at the same time with having the over 15-year olds jabbed, also planned for November 26. The teenagers and adults were due to receive the locally produced swine flu vaccine.
It was also last week when the Government decided to increase the number of anti-swine flu vaccine doses from five to ten millions.